Shares of Starbucks took a dive after delivering weaker-than-expected sales results for the latest quarter. Jason Moser, Analyst at Motley Fool, joined us to break down the numbers. Global same-store sales rose 2%, below estimates of 3%. Despite raking in over $6 billion in a quarter for the first time, investors were disappointed that the company fell short of the $6.18 billion projected. Moser thinks it is a bit of an overreaction for investors to believe the company is a business in decline. The analyst added that China will continue to be a major growth opportunity for Starbucks. Same-store sales in China grew 6%, while revenue in Q1 grew 30%. Starbucks added 1.4 million rewards members in the quarter, bringing the total to 14.2 million. With 75 million unique visitors, Moser questions Starbucks' ability to capitalize on the program. He also noted that Kevin Johnson needs to step it up before Wall Street loses confidence in his ability to lead the company.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More